The Amplify Alternative Harvest ETF (MJ) is the oldest and one of the most widely followed exchange-traded funds dedicated to the global cannabis industry. Launched in December 2015 and now managed by Amplify Investments, the fund tracks the Prime Alternative Harvest Index, holding companies involved in the legal cultivation, production, marketing, and distribution of cannabis and related products. After a steep multi-year decline, the central question for investors is whether the fund can climb back toward the $30 level.
Because MJ is an ETF, it does not have the individual analyst price targets that brokerage research assigns to individual stocks. The $30 objective is therefore a fallback figure drawn from public technical price forecasts and market commentary rather than a published analyst consensus. Independent technical-forecast services have cited six-month and one-year objectives for the fund in the roughly $30 to $33 range, while $30 also functions as a natural psychological price level that sits comfortably between the fund's current price and its 52-week high. It should be read as a benchmark drawn from public discussion, not as a prediction or a guaranteed outcome.
With MJ trading near $22.30, a move to $30 would require an advance of approximately 35%, a substantial move for a thematic fund already near the bottom of its 52-week range. The fund began 2026 near $29.79 and has since surrendered about a quarter of its value, leaving it close to its 52-week low of $21.05 and roughly 95% below its 2018 all-time high. Reaching $30 would require first reclaiming the 50-day range high near $27.80 and then pushing through the psychologically important $30 barrier, a process that would likely need a genuine improvement in cannabis-industry fundamentals rather than a short-term sentiment bounce.
Several factors could help MJ climb. Federal cannabis rescheduling or banking reform in the United States would be a meaningful catalyst for the industry, improving access to capital and institutional flows. The fund also benefits from diversified global exposure, with meaningful weight in Canadian producers such as Cronos Group (CRON), Tilray Brands (TLRY), and Canopy Growth (CGC), as well as U.S.-focused names like SNDL (SNDL) and Village Farms International (VFF). Improved profitability, rationalized capacity, and any consolidation across the sector could lift valuations, while a rotation back into high-beta thematic funds would provide a supportive tailwind.
The risks are substantial. MJ is extraordinarily concentrated, with its top holding, the Amplify Seymour Cannabis ETF (CNBS), accounting for roughly 49% of assets, meaning the fund behaves in part like a fund-of-funds with layered fees. Healthcare exposure exceeds three-quarters of the portfolio, and Canadian names represent a large share of holdings. Persistent share dilution, weak consumer demand, price compression, and slow-moving U.S. regulatory reform have weighed on the sector for years. The fund's small size — roughly $95 million to $100 million in AUM (assets under management) — and thin average trading volume also add liquidity and closure risk. Any further delay in reform or another leg down in producer earnings would make a 35% advance difficult to sustain.
Technically, MJ sits in a long-term downtrend. The $21.05 area marks the 52-week low and a key support level, while the $27.80 zone represents the top of the recent 50-day range and an initial resistance level. Above that, $30 is both a round-number psychological level and a widely cited technical objective. The 52-week high near $46.75 serves as a reminder of how quickly the fund can rally during periods of sector enthusiasm, but it also underscores the wide trading range that makes durable gains hard to lock in.
Because the $30 target is technical rather than analyst-derived, it carries no formal research horizon, though technical forecasts commonly look out six to twelve months. Investors should monitor U.S. federal rescheduling and banking legislation, quarterly earnings and cash-burn trends from major holdings such as Tilray, Canopy Growth, and Aurora Cannabis, any additional reverse splits or dilution, fund flows into and out of MJ and peer cannabis ETFs, and interest-rate policy, which influences sentiment toward speculative thematic funds. Sustained inflows and improving producer margins would be among the clearest signs that a move toward $30 is becoming more plausible.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on shifting market conditions, technical behavior, and AI-driven analysis. For a volatile, news-sensitive fund like MJ, such signals can help traders identify opportunities, track positions, and detect changing trends more efficiently than manual chart review. Investors interested in applying a systematic, signal-based approach to the cannabis trade can explore these tools to complement their own research and risk management.
Can MJ reach $30? The objective is a publicly discussed technical benchmark rather than an analyst-derived price target, and it implies a roughly 35% gain from the current price near $22.30. That is a substantial move for a concentrated, deeply beaten-down thematic fund, but not an unprecedented one given the fund's 52-week high near $46.75. Support would most likely come from genuine U.S. regulatory progress and stabilizing producer fundamentals, while the principal obstacles remain concentration, dilution, weak demand, and slow reform. There is no analyst consensus to lean on, and no guarantee the fund reclaims $30. Investors should watch regulatory headlines, holdings-level earnings, and fund flows before drawing any conclusions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, MJ has been closely correlated with MSOS. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if MJ jumps, then MSOS could also see price increases.